TSANZ SIG Orals: Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease (OLIV) 2
Tracks
TSANZ Orals
| Sunday, March 23, 2025 |
| 1:00 PM - 2:30 PM |
Speaker
Dr Pamela Karas
Advanced Trainee
Royal Prince Alfred Hospital
The use of antifibrotics in non-idiopathic pulmonary fibrosis: a descriptive cohort study of participants in the Australasian interstitial lung disease registry
1:00 PM - 1:15 PM
Dr John Mackintosh
Respiratory Physician
The Prince Charles Hospital
Combined deep learning algorithms demonstrate that both computed tomography phenotype and anatomical biomarkers are predictive of prognosis and progression in idiopathic pulmonary fibrosis
1:15 PM - 1:30 PM
Dr John Mackintosh
Respiratory Physician
The Prince Charles Hospital
Deep learning quantitative computed tomography analysis in the Australian idiopathic pulmonary fibrosis registry
1:30 PM - 1:45 PM
Miss Emma Marshall
Research Assistant
Institute for Breathing and Sleep
Geographical disparities for phase II/III pharmaceutical randomised controlled trials in Interstitial lung disease
1:45 PM - 2:00 PM
Dr Claire McLaughlin
Respiratory Advanced Trainee
Fiona Stanley Hospital
Australasian interstitial lung disease patients in 2024- a registry study
2:00 PM - 2:15 PM
Dr Ling-ling Tsai
Post-doctoral Research Fellowship
The University Of Sydney
Diagnostic agreement between interstitial lung disease multidisciplinary-meetings: A bi-national study
2:15 PM - 2:30 PM
